Re: Should we delay covid-19 vaccination in children?
Dear Editor,
Let's not forget that there is no long-term follow-up with these new vaccines and soon there will be no control group left because almost everyone will have had one of the mRNA vaccines.
Vaccinating a vulnerable patient in his or her 80s is one thing. If their high risk from Covid can be reduced, then any possible long-term adverse reactions that may develop years later are almost academic. This is completely reversed for children. Should we give a still fairly experimental vaccine technology with no long-term safety profile to children who are at almost no risk from the disease? And if so, how do we justify that?
Rapid Response:
Re: Should we delay covid-19 vaccination in children?
Dear Editor,
Let's not forget that there is no long-term follow-up with these new vaccines and soon there will be no control group left because almost everyone will have had one of the mRNA vaccines.
Vaccinating a vulnerable patient in his or her 80s is one thing. If their high risk from Covid can be reduced, then any possible long-term adverse reactions that may develop years later are almost academic. This is completely reversed for children. Should we give a still fairly experimental vaccine technology with no long-term safety profile to children who are at almost no risk from the disease? And if so, how do we justify that?
Competing interests: No competing interests